The IPO is a complete OFS by existing shareholder Helix Investment Holdings
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
Soluplus branded excipient play a critical role in enabling the drug development process for poorly soluble active pharmaceutical ingredients
Move to increase affordability and accessibility for heart failure patients across the country
It offers quick relief in various types of Coughs, Colds and Sore Throat,
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
Subscribe To Our Newsletter & Stay Updated